Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation

Preterm birth, defined as any birth before 37 weeks of completed gestation, poses adverse health risks to both mothers and infants. Despite preterm birth being associated with several risk factors, its relationship to maternal metabolism remains unclear, especially in first-time mothers. Aims of the...

Full description

Bibliographic Details
Main Authors: Ying-Chieh Han, Katarina Laketic, Kylie K. Hornaday, Donna M. Slater, Chunlong Mu, Suzanne C. Tough, Jane Shearer
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/16/5/595
_version_ 1797264116241399808
author Ying-Chieh Han
Katarina Laketic
Kylie K. Hornaday
Donna M. Slater
Chunlong Mu
Suzanne C. Tough
Jane Shearer
author_facet Ying-Chieh Han
Katarina Laketic
Kylie K. Hornaday
Donna M. Slater
Chunlong Mu
Suzanne C. Tough
Jane Shearer
author_sort Ying-Chieh Han
collection DOAJ
description Preterm birth, defined as any birth before 37 weeks of completed gestation, poses adverse health risks to both mothers and infants. Despite preterm birth being associated with several risk factors, its relationship to maternal metabolism remains unclear, especially in first-time mothers. Aims of the present study were to identify maternal metabolic disruptions associated with preterm birth and to evaluate their predictive potentials. Blood was collected, and the serum harvested from the mothers of 24 preterm and 42 term births at 28–32 weeks gestation (onset of the 3rd trimester). Serum samples were assayed by untargeted metabolomic analyses via liquid chromatography/mass spectrometry (QTOF-LC/MS). Metabolites were annotated by inputting the observed mass-to-charge ratio into the Human Metabolome Database (HMDB). Analysis of 181 identified metabolites by PLS-DA modeling using SIMCA (v17) showed reasonable separation between the two groups (CV-ANOVA, <i>p</i> = 0.02). Further statistical analysis revealed lower serum levels of various acyl carnitines and amino acid metabolites in preterm mothers. Butenylcarnitine (C4:1), a short-chain acylcarnitine, was found to be the most predictive of preterm birth (AUROC = 0.73, [CI] 0.60–0.86). These observations, in conjuncture with past literature, reveal disruptions in fatty acid oxidation and energy metabolism in preterm primigravida. While these findings require validation, they reflect altered metabolic pathways that may be predictive of preterm delivery in primigravida.
first_indexed 2024-04-25T00:23:47Z
format Article
id doaj.art-ced151e34e524cf68bc47f51514691e1
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-04-25T00:23:47Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-ced151e34e524cf68bc47f51514691e12024-03-12T16:51:53ZengMDPI AGNutrients2072-66432024-02-0116559510.3390/nu16050595Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary InvestigationYing-Chieh Han0Katarina Laketic1Kylie K. Hornaday2Donna M. Slater3Chunlong Mu4Suzanne C. Tough5Jane Shearer6Department of Biomedical Engineering, Faculty of Engineering, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaDepartment of Biomedical Engineering, Faculty of Engineering, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaDepartment of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaDepartment of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaAlberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaAlberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaDepartment of Biomedical Engineering, Faculty of Engineering, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, CanadaPreterm birth, defined as any birth before 37 weeks of completed gestation, poses adverse health risks to both mothers and infants. Despite preterm birth being associated with several risk factors, its relationship to maternal metabolism remains unclear, especially in first-time mothers. Aims of the present study were to identify maternal metabolic disruptions associated with preterm birth and to evaluate their predictive potentials. Blood was collected, and the serum harvested from the mothers of 24 preterm and 42 term births at 28–32 weeks gestation (onset of the 3rd trimester). Serum samples were assayed by untargeted metabolomic analyses via liquid chromatography/mass spectrometry (QTOF-LC/MS). Metabolites were annotated by inputting the observed mass-to-charge ratio into the Human Metabolome Database (HMDB). Analysis of 181 identified metabolites by PLS-DA modeling using SIMCA (v17) showed reasonable separation between the two groups (CV-ANOVA, <i>p</i> = 0.02). Further statistical analysis revealed lower serum levels of various acyl carnitines and amino acid metabolites in preterm mothers. Butenylcarnitine (C4:1), a short-chain acylcarnitine, was found to be the most predictive of preterm birth (AUROC = 0.73, [CI] 0.60–0.86). These observations, in conjuncture with past literature, reveal disruptions in fatty acid oxidation and energy metabolism in preterm primigravida. While these findings require validation, they reflect altered metabolic pathways that may be predictive of preterm delivery in primigravida.https://www.mdpi.com/2072-6643/16/5/595pregnancymetabolismprimigravidascreeningmetabolomicsmass spectrometry
spellingShingle Ying-Chieh Han
Katarina Laketic
Kylie K. Hornaday
Donna M. Slater
Chunlong Mu
Suzanne C. Tough
Jane Shearer
Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation
Nutrients
pregnancy
metabolism
primigravida
screening
metabolomics
mass spectrometry
title Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation
title_full Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation
title_fullStr Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation
title_full_unstemmed Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation
title_short Maternal Acylcarnitine Disruption as a Potential Predictor of Preterm Birth in Primigravida: A Preliminary Investigation
title_sort maternal acylcarnitine disruption as a potential predictor of preterm birth in primigravida a preliminary investigation
topic pregnancy
metabolism
primigravida
screening
metabolomics
mass spectrometry
url https://www.mdpi.com/2072-6643/16/5/595
work_keys_str_mv AT yingchiehhan maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation
AT katarinalaketic maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation
AT kyliekhornaday maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation
AT donnamslater maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation
AT chunlongmu maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation
AT suzannectough maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation
AT janeshearer maternalacylcarnitinedisruptionasapotentialpredictorofpretermbirthinprimigravidaapreliminaryinvestigation